Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 263 | 273 | 291 | 289 | 335 | 333 | 337 | 353 | 394 | 365 | 388 | 411 |
| Expenses | 202 | 211 | 228 | 223 | 257 | 256 | 257 | 275 | 301 | 282 | 299 | 332 |
| Operating Profit | 61 | 62 | 63 | 65 | 78 | 76 | 80 | 78 | 92 | 83 | 89 | 79 |
| OPM % | 23% | 23% | 22% | 23% | 23% | 23% | 24% | 22% | 23% | 23% | 23% | 19% |
| Other Income | 3 | 8 | 10 | 7 | 7 | 7 | 7 | 13 | 11 | 3 | 11 | 11 |
| Interest | 12 | 1 | 1 | 1 | 1 | 3 | 6 | 8 | 8 | 8 | 9 | 13 |
| Depreciation | 11 | 11 | 10 | 11 | 14 | 14 | 18 | 21 | 21 | 22 | 23 | 26 |
| Profit before tax | 41 | 58 | 62 | 60 | 70 | 67 | 63 | 62 | 74 | 57 | 68 | 51 |
| Tax % | 19% | 25% | 27% | 26% | 26% | 22% | 28% | 29% | 23% | 25% | 26% | 26% |
| Net Profit | 34 | 44 | 45 | 45 | 52 | 52 | 45 | 44 | 57 | 42 | 50 | 38 |
| EPS in Rs | 1.03 | 1.33 | 1.37 | 1.36 | 1.58 | 1.59 | 1.38 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 463 | 486 | 733 | 893 | 1,073 | 1,302 | 1,500 | 1,558 |
| Expenses | 379 | 419 | 580 | 691 | 831 | 999 | 1,156 | 1,214 |
| Operating Profit | 84 | 67 | 153 | 201 | 242 | 303 | 343 | 344 |
| OPM % | 18% | 14% | 21% | 23% | 23% | 23% | 23% | 22% |
| Other Income | 0 | 4 | 4 | 8 | 22 | 25 | 37 | 35 |
| Interest | 26 | 39 | 44 | 42 | 26 | 11 | 33 | 37 |
| Depreciation | 26 | 31 | 36 | 39 | 42 | 57 | 88 | 93 |
| Profit before tax | 33 | 2 | 77 | 129 | 195 | 261 | 260 | 249 |
| Tax % | 10% | 248% | 34% | 43% | 10% | 26% | 25% | |
| Net Profit | 30 | -2 | 51 | 73 | 177 | 194 | 194 | 188 |
| EPS in Rs | 1.17 | -0.09 | 2.01 | 2.58 | 5.39 | 5.89 | 5.92 | 5.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 4% | 3% | 3% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 25% | 19% | 15% | ||
| Compounded Profit Growth | % | 143% | 37% | -1% | ||
| Stock Price CAGR | % | % | 7% | -14% | ||
| Return on Equity | % | 17% | 16% | 13% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 57 | 66 | 66 | 66 |
| Reserves | 186 | 188 | 243 | 309 | 1,103 | 1,291 | 1,479 |
| Borrowings | 272 | 426 | 495 | 469 | 0 | 393 | 584 |
| Other Liabilities | 94 | 124 | 120 | 151 | 112 | 168 | 235 |
| Total Liabilities | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 |
| Fixed Assets | 435 | 630 | 684 | 720 | 718 | 978 | 1,384 |
| CWIP | 10 | 26 | 27 | 29 | 74 | 185 | 129 |
| Investments | 2 | 7 | 3 | 2 | 17 | 507 | 486 |
| Other Assets | 156 | 126 | 195 | 235 | 473 | 247 | 364 |
| Total Assets | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 74 | 123 | 137 | 176 | 115 | 267 | 268 |
| Cash from Investing Activity | -43 | -295 | -84 | -94 | -246 | -497 | -442 |
| Cash from Financing Activity | -32 | 184 | 32 | -51 | 128 | 297 | 136 |
| Net Cash Flow | -1 | 12 | 85 | 31 | -3 | 66 | -38 |
| Free Cash Flow | 46 | -118 | 46 | 100 | 29 | -60 | -234 |
| CFO/OP | 106% | 198% | 95% | 97% | 68% | 109% | 97% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 16 | 14 | 19 | 19 | 12 | 18 |
| Inventory Days | 64 | 48 | 39 | 44 | 41 | 38 | 49 |
| Days Payable | 268 | 217 | 157 | 164 | 120 | 99 | 121 |
| Cash Conversion Cycle | -169 | -152 | -104 | -101 | -59 | -49 | -54 |
| Working Capital Days | 17 | -7 | -24 | -24 | -5 | -19 | -21 |
| ROCE % | 7% | 17% | 21% | 22% | 18% | 15% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FIIs | 4.62% | 3.96% | 4.17% | 6.06% | 8.84% | 10.04% | 10.04% | 9.77% | 9.06% | 8.48% | 8.48% | 9.37% |
| DIIs | 12.69% | 13.92% | 14.16% | 13.85% | 13.46% | 15.75% | 15.64% | 15.82% | 16.97% | 17.44% | 17.01% | 16.51% |
| Public | 41.80% | 41.19% | 40.76% | 39.18% | 36.79% | 33.31% | 33.43% | 33.51% | 33.08% | 33.17% | 33.60% | 33.20% |
| No. of Shareholders | 54,782 | 39,348 | 35,107 | 35,797 | 34,081 | 33,914 | 33,956 | 34,192 | 34,361 | 33,620 | 32,985 | 33,194 |
Fundamentals
Market Cap₹ 8,591 Cr.
Current Price₹ 262
Stock P/E44.9
Book Value₹ 47.1
ROCE14.8 %
ROE13.1 %
Dividend Yield0.08 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)15%
Compounded Profit Growth (TTM)-1%
Consolidated figures.
Valuation
Market capRs 8,519 Cr
Enterprise valueRs 8,853 Cr
P/E (TTM)45.41x
Price to book23.29x
Price to sales5.47x
EV / EBITDA23.34x
EV / EBIT30.90x
EV / sales5.68x
Price to cash flow48.29x
Earnings yield2.20%
Profitability
Operating margin (excl. other income)22.55%
Operating margin (incl. other income)23.48%
EBITDA margin24.35%
Pre-tax margin16.00%
Net profit margin12.04%
Net margin, latest quarter9.12%
ROE22.12%
ROCE21.07%
ROA7.70%
ROE, 3-year average13.45%
ROCE, 3-year average14.88%
ROA, 3-year average4.46%
ROIC (approx.)23.19%
Tax rate43.36%
Other income / net worth2.25%
Growth
Sales growth (latest year)21.75%
Profit growth (latest year)42.60%
Sales CAGR, 3 years24.46%
Profit CAGR, 3 years35.01%
Sales growth QoQ5.97%
Profit growth QoQ-25.33%
Sales growth YoY (latest quarter)16.44%
Profit growth YoY (latest quarter)-14.58%
Per share
EPS (TTM)Rs 5.72
EPS (latest year)Rs 12.90
EPS (latest quarter)Rs 1.14
EPS, 3-year averageRs 7.50
Book value per shareRs 11.15
Sales per shareRs 47.52
Cash flow per shareRs 5.38
Free cash flow per shareRs -7.14
Efficiency
Asset turnover0.91x
Fixed asset turnover1.24x
Inventory turnover14.14x
Inventory days26 days
Debtor days19 days
Debtors turnover19.53x
Creditor days121 days
Cash conversion cycle-54 days
Working capital days-21 days
Leverage
Total debtRs 469 Cr
Cash and bankRs 134 Cr
Net debtRs 334 Cr
Debt to equity1.28x
Net debt / EBITDA0.88x
Interest coverage7.69x
Current ratio (filing 2026-03-31)3.02x
Quick ratio (filing 2026-03-31)2.85x
Trade payables (filing 2026-03-31)Rs 96 Cr
Owners' fund to total sources37.11%
Debt to assets47.55%
Cash flow
Cash from Operating Activity (latest year)Rs 176 Cr
Cash from Investing Activity (latest year)Rs -94 Cr
Cash from Financing Activity (latest year)Rs -51 Cr
Net Cash Flow (latest year)Rs 31 Cr
Free cash flow (latest year)Rs -234 Cr
FCFE (approx.: FCF + change in debt)Rs -261 Cr
Cash from ops / profit, 5 years1.40x
Sales to cash flow5.06x
Statement figures
Net sales (TTM)Rs 1,558 Cr
Net sales (latest year)Rs 893 Cr
Sales (latest quarter)Rs 411 Cr
Operating profit excl. other income (latest year)Rs 201 Cr
Operating profit (latest quarter)Rs 79 Cr
Other income (TTM)Rs 35 Cr
EBITDA (TTM)Rs 379 Cr
PBDT (TTM)Rs 342 Cr
Profit before tax (TTM)Rs 249 Cr
Tax (latest year)Rs 56 Cr
Net profit (TTM)Rs 188 Cr
Net profit (latest year)Rs 73 Cr
Net profit (latest quarter)Rs 37 Cr
Depreciation (TTM)Rs 93 Cr
Depreciation (latest quarter)Rs 26 Cr
Interest (TTM)Rs 37 Cr
Cost of goods sold (latest year)Rs 269 Cr
Total expenditure (latest year)Rs 691 Cr
Total income (latest year)Rs 901 Cr
Share capitalRs 57 Cr
ReservesRs 309 Cr
Shareholders' fundsRs 366 Cr
Total assetsRs 986 Cr
Net blockRs 720 Cr
Capital work in progressRs 29 Cr
InvestmentsRs 2 Cr
ReceivablesRs 46 Cr
InventoryRs 19 Cr
Other liabilitiesRs 151 Cr
Shares outstanding (crore)32.78
Ownership
Promoter holding40.91% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 45.4 is at the 20th percentile of its own 2.5-year range
(median 49.8, low 42.5, high 305.8).
P/B 23.29 is at the 3th percentile (median 32.59).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | JLHL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.0% | -2.8% | -0.2 pts |
| 1 month | -11.4% | -6.8% | -4.6 pts |
| 3 months | -10.8% | -7.6% | -3.2 pts |
| 6 months | +1.4% | +0.4% | +1.0 pts |
| 1 year | -15.7% | -9.9% | -5.8 pts |
| 2 years | -7.1% | -13.6% | +6.5 pts |
| 3 years | +20.7% | +14.2% | +6.6 pts |
35 mutual fund schemes hold about ₹1,323 Cr.
Over three months 29 bought more and 3 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| SBI Multicap Fund | 2.41% | 591 | +7% |
| SBI Healthcare Opp Fund | 2.55% | 148 | +12% |
| HDFC Multi Cap Fund | 0.61% | 126 | +374% |
| HDFC Small Cap Fund | 0.30% | 126 | +100% |
| HDFC Pharma and Healthcare Fund | 1.94% | 64 | +700% |
| Aditya Birla SL Multi-Cap Fund | 0.75% | 57 | +9% |
| UTI Healthcare Fund | 2.17% | 31 | +24% |
| UTI Small Cap Fund | 0.40% | 21 | +12% |
| Aditya Birla SL Pharma & Healthcare Fund | 1.76% | 19 | +7% |
| HDFC Consumption Fund | 1.85% | 19 | +35% |
| DSP Healthcare Fund | 0.40% | 15 | +17% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 0.58% | 14 | +9% |
| WOC Flexi Cap Fund | 0.16% | 14 | +4% |
| ICICI Pru Exports & Services Fund | 0.82% | 13 | +44% |
| ICICI Pru Exports & Services Fund | 0.82% | 12 | +44% |
| ICICI Pru Small Cap Fund | 0.09% | 9 | +11% |
| ICICI Pru Small Cap Fund | 0.09% | 8 | +11% |
| WOC Pharma and Healthcare Fund | 0.87% | 8 | +34% |
| Tata Children's Fund | 1.77% | 6 | +18% |
| Taurus Ethical Fund | 1.06% | 5 | +7% |
| WOC Multi Cap Fund | 0.11% | 5 | +3% |
| The Wealth Company Flexi Cap Fund | 1.22% | 3 | +100% |
| UTI Infrastructure Fund | 0.13% | 3 | +19% |
| The Wealth Company Small Cap Fund | 2.47% | 3 | +35% |
| PGIM India Healthcare Fund | 1.77% | 2 | -4% |
Red flags
F-score 7 of 8| look | Share dilution Share count up 11% in a year, 11% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹411 Cr +16.4% vs Jun 2025.
Net profit ₹38 Cr -13.6%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-07-24 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share | 0.2000 |
| 2026-05-22 | Interim Dividend - Re 1 Per Share | |
| 2025-07-04 | Dividend - Re 1 Per Share | |
| 2024-08-02 | Dividend - Re 1 Per Share |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Jupiter Life Line Hospitals Ltd?
Jupiter Life Line Hospitals Ltd (JLHL) has a market capitalisation of Rs 8,591 Cr. at the 2026-10-01 close.
What is the P/E ratio of Jupiter Life Line Hospitals Ltd?
Jupiter Life Line Hospitals Ltd trades at a P/E of 44.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Jupiter Life Line Hospitals Ltd's latest quarterly results?
In the Jun 2026 quarter, Jupiter Life Line Hospitals Ltd sales was Rs 411 Cr (+16.4% vs Jun 2025) and net profit was Rs 38 Cr.
What is the 52-week high and low of Jupiter Life Line Hospitals Ltd?
The 52-week high is Rs 340.00 and the 52-week low is Rs 235.60.